Literature DB >> 17717660

Application of cell culture enrichment for improving the sensitivity of mycoplasma detection methods based on nucleic acid amplification technology (NAT).

Hyesuk Kong1, Dmitriy V Volokhov, Joseph George, Pranvera Ikonomi, Donna Chandler, Christine Anderson, Vladimir Chizhikov.   

Abstract

Herein, we present data demonstrating that the application of initial cell culture enrichment could significantly improve mycoplasma testing methods based on the nucleic acid amplification technology (NAT) including a polymerase chain reaction (PCR)/microarray method. The results of the study using Vero cells demonstrated that this cell culture is able (1) to support efficient growth of mycoplasmas of primary interest, i.e., species found to be cell line contaminants, (2) to increase the sensitivity of NAT assay to the detection limits of the conventional broth/agar culture methods, and (3) to reduce the time required for mycoplasma testing fourfold in comparison with the conventional methods. Detection and identification of mycoplasmal agents were conducted using a modified PCR/microarray assay based on genetic differences among Mollicutes in the 16S-23S rRNA intergenic transcribed spacer (ITS). The application of nano-gold/silver enhancement technology instead of previously used fluorescent dyes significantly simplified the readout of microarray results and allowed us to avoid using expensive scanning equipment. This modification has the potential to expand the implementation of microarray techniques into laboratories involved in diagnostic testing of mycoplasma contamination in cell substrates and potentially in other biological and pharmaceutical products.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17717660     DOI: 10.1007/s00253-007-1135-1

Source DB:  PubMed          Journal:  Appl Microbiol Biotechnol        ISSN: 0175-7598            Impact factor:   4.813


  8 in total

1.  Consensus guidance for banking and supply of human embryonic stem cell lines for research purposes.

Authors: 
Journal:  Stem Cell Rev Rep       Date:  2009-12       Impact factor: 5.739

Review 2.  Infectious problems associated with transplantation of cells differentiated from pluripotent stem cells.

Authors:  Outi Hovatta
Journal:  Semin Immunopathol       Date:  2011-04-09       Impact factor: 9.623

3.  Optimized PCR-based detection of mycoplasma.

Authors:  Paige L Dobrovolny; Dan Bess
Journal:  J Vis Exp       Date:  2011-06-20       Impact factor: 1.355

4.  Real-time PCR assay is superior to other methods for the detection of mycoplasma contamination in the cell lines of the National Cell Bank of Iran.

Authors:  Vahid Molla Kazemiha; Shahin Bonakdar; Amir Amanzadeh; Shahram Azari; Arash Memarnejadian; Shirin Shahbazi; Mohammad Ali Shokrgozar; Reza Mahdian
Journal:  Cytotechnology       Date:  2015-03-06       Impact factor: 2.058

5.  Sensitivity of biochemical test in comparison with other methods for the detection of mycoplasma contamination in human and animal cell lines stored in the National Cell Bank of Iran.

Authors:  Vahid Molla Kazemiha; Amir Amanzadeh; Arash Memarnejadian; Shahram Azari; Mohammad Ali Shokrgozar; Reza Mahdian; Shahin Bonakdar
Journal:  Cytotechnology       Date:  2014-02-04       Impact factor: 2.058

6.  Biological enrichment of Mycoplasma agents by cocultivation with permissive cell cultures.

Authors:  Dmitriy V Volokhov; Hyesuk Kong; Joseph George; Christine Anderson; Vladimir E Chizhikov
Journal:  Appl Environ Microbiol       Date:  2008-07-07       Impact factor: 4.792

Review 7.  Fluorescence-based bioassays for the detection and evaluation of food materials.

Authors:  Kentaro Nishi; Shin-Ichiro Isobe; Yun Zhu; Ryoiti Kiyama
Journal:  Sensors (Basel)       Date:  2015-10-13       Impact factor: 3.576

8.  Comparison of different NAT assays for the detection of microorganisms belonging to the class Mollicutes.

Authors:  O Vega-Orellana; J B Poveda; R S Rosales; J M Bradbury; C G Poveda; L E Mederos-Iriarte; M M Tavío; A S Ramírez
Journal:  BMC Vet Res       Date:  2017-06-24       Impact factor: 2.741

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.